GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Cash Flow for Dividends

Embecta (FRA:JX7) Cash Flow for Dividends : €-32 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Embecta Cash Flow for Dividends?

Embecta's cash flow for dividends for the three months ended in Dec. 2024 was €-8 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2024 was €-32 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Embecta's quarterly payment of dividends declined from Jun. 2024 (€-8 Mil) to Sep. 2024 (€-8 Mil) but then increased from Sep. 2024 (€-8 Mil) to Dec. 2024 (€-8 Mil).

Embecta's annual payment of dividends increased from Sep. 2022 (€-9 Mil) to Sep. 2023 (€-32 Mil) but then declined from Sep. 2023 (€-32 Mil) to Sep. 2024 (€-31 Mil).

Embecta Cash Flow for Dividends Historical Data

The historical data trend for Embecta's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Embecta Cash Flow for Dividends Chart

Embecta Annual Data
Trend Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Cash Flow for Dividends
Get a 7-Day Free Trial - - -8.69 -32.23 -31.09

Embecta Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.89 -7.91 -7.99 -7.84 -8.40

Embecta Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-32 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Embecta Cash Flow for Dividends Related Terms

Thank you for viewing the detailed overview of Embecta's Cash Flow for Dividends provided by GuruFocus.com. Please click on the following links to see related term pages.

Embecta Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Embecta Corp (FRA:JX7) » Definitions » Cash Flow for Dividends
Comparable Companies
STAA PLSE ANGO NNNN SMTI KMTS OSUR BLFS UTMD PDEX ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD TSE:4543 OCSE:COLO B XSWX:STMN XPAR:DIM
Traded in Other Exchanges
EMBC:USA
Address
300 Kimball Drive, Suite 300, Parsippany, NJ, USA, 07054
Website
https://www.embecta.com
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Embecta Headlines

No Headlines